Current role
Biotechnology · Healthcare
Board Member
2022-12-26–present
Nassim Usman, Ph.D.
Board Member
Gyre Therapeutics, Inc. (GYRE)Equibles does not estimate personal net worth.
About Nassim Usman, Ph.D.
Nassim Usman, Ph.D. is recorded as Board Member at Gyre Therapeutics, Inc. (GYRE) since December 26, 2022. Gyre Therapeutics, Inc. reported in an 8-K filed December 27, 2022 that Nassim Usman, Ph.D. was appointed Director, effective December 26, 2022. Gyre Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Gyre Therapeutics, Inc. includes Charles Wu (CEO and Board Member), Dr. Han Ying (CEO), Dr. Ying Luo (CEO and Board Member) and 7 others.
“The Board appointed Nassim Usman, Ph.D. to serve as a Class III director with a term expiring at Catalyst's 2024 annual meeting of the stockholders and until such time as his successor is duly elected and qualified, or until his earlier death, resignation or removal.”
Affiliation history
-
Current
2022-12-26–present
Company network
Leadership on record at Gyre Therapeutics, Inc.
- Charles Wu CEO, Board Member
- Dr. Han Ying CEO
- Dr. Ying Luo CEO, Board Member
- Ping Zhang CEO, Board Member
- Ying Luo CEO, Board Member
- Ying Luo, Ph.D. CEO, Board Member
- Augustine Lawlor Chairman, Board Member
- Songjiang Ma Chairman, Board Member
- Clinton Musil CFO
- Fletcher Payne CFO